menu search

Additional detailed analyses from phase 2 study 201 of lecanemab published as three papers in peer-reviewed journals

TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (...

March 30, 2023, 11:30 pm

Sutro biopharma reports full year 2022 financial results, business highlights and select anticipated milestones

– Sutro plans to initiate a phase 2/3 registration-directed study of luvelta for patients with platin...

March 30, 2023, 8:30 pm

Why shares of viking therapeutics skyrocketed this week

Viking Therapeutics is seeing promise in an obesity drug. The company said it plans another phase 1 tri...

March 30, 2023, 2:06 pm

Annovis and buntanetap: asymmetric risk/reward ahead of parkinson's data readout

Lead asset buntanetap represents a differentiated, potentially disease-modifying mechanism of action in neurodegenerative diseases. Interim ...

March 30, 2023, 12:00 pm

Avidity's stock falls after sharing additional data about partial clinical hold

Shares of Avidity Biosciences Inc. RNA, +0.55% fell about 3.0% in premarket trading on Thursday after the company said a partial clinical hold on its ...

March 30, 2023, 7:52 am

Valneva q4: resilient pipeline and partnership with pfizer, reinforcing a promising future

Valneva's pipeline and high-stakes clinical catalysts warrant a buy rating, despite the setback in its Lyme disease ...

March 29, 2023, 10:56 pm

Warner music group to cut around 4% of its overall workforce

Warner Music Group Corp. WMG on Wednesday said it planned to cut about 270 jobs, or around 4% of its overall workforce, with most of them to be comple...

March 29, 2023, 5:44 pm

Bioxytran's positive phase 2 trial results featured in ‘vaccines' peer-reviewed journal

Bioxytran said positive top-line safety and efficacy results from the company's randomized, placebo-controlled ...

March 29, 2023, 4:04 pm

Intra-cellular (itci) depression drug meets study goal, stock up

Intra-Cellular Therapeutics (ITCI) announces positive top-line data from its phase III study evaluating...

March 29, 2023, 1:46 pm

Kulr technology says appointment of ex goldman sachs executive shawn canter as cfo further strengthens leadership

KULR Technology Group Inc (NYSE:KULR) announced it has strengthened its executive leadership team with the appointment of Shawn Canter as its new chie...

March 29, 2023, 9:23 am

U.k. regulator to refer broadcom deal for vmware for further review

The U.K. Competition and Markets Authority followed through on a threat made last week to refer the agreed acquisition by Broadcom AVGOof VMware VMW f...

March 29, 2023, 6:18 am

Should you buy viking therapeutics stock after it skyrocketed over 60%?

Viking Therapeutics announced promising results on Tuesday from a phase 1 study of obesity drug VX2735....

March 29, 2023, 5:54 am

Unity (unx) down on disappointing results from wet amd study

Unity's (UBX) phase II ENVISION study on UBX1325 fails to meet the non-inferiority threshold compared t...

March 28, 2023, 4:45 pm

Here's why viking therapeutics rose over 50% on obesity drug data

Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive ...

March 28, 2023, 1:01 pm

Why is monopar therapeutics (mnpr) stock down 47% today?

Monopar Therapeutics (NASDAQ: MNPR ) stock is taking a beating on Tuesday after the company revealed lackluster clinical trial results. These results ...

March 28, 2023, 9:19 am

Allarity's stock falls after saying enrollment in two clinical trials is slow

Shares of Allarity Therapeutics Inc. ALLR, -4.51% plunged 17% in premarket trading on Tuesday after the company told investors that it's struggled to ...

March 28, 2023, 8:34 am

Viking's stock rallies as it announces trial for oral version of obesity drug

Shares of Viking Therapeutics Inc. VKTX, +3.05% soared about 45% in premarket trading on Tuesday after the company said it started a ...

March 28, 2023, 8:19 am

Intra-cellular's stock jumps on new data for depression drug

Shares of Intra-Cellular Therapies Inc. ITCI, +2.46% jumped about 15% in premarket trading on Tuesday after the company said its experimental treatmen...

March 28, 2023, 8:16 am

Revive therapeutics enrols first patient in psilocybin clinical study for methamphetamine use disorder

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) said it has enrolled the first patient in its phase I/II...

March 28, 2023, 7:47 am

Tiziana life sciences plans to accept us fda recommendations and start phase 2 study in q3 2023

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said it has received feedback based on the US Food and Drug Administration (FDA) Type C meeting minutes relate...

March 28, 2023, 7:31 am


Search within

Pages Search Results: